LONDON, April 15 According to the International Diabetes Federation the adult population with diabetes in 2010 is likely to reach 55.2 million in Europe and around 285 million people worldwide. Estimates by the World Health Organisation (WHO) also record the global increase of diabetes at an alarming rate: By 2030 the number of people with diabetes could rise to 438 million around the world.
Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
Healthcare systems across the globe have recognized the epidemic nature of this chronic disease and are encouraging new technologies to counter its adverse effects. While the national prevalence rate of diabetes varies from country to country in Europe, the International Diabetes Federation indicates, that the healthcare expenditure on diabetes in 2010 is likely to be US$ 106 billion in Europe alone, representing 28 per cent of the global expenditure. Continuous glucose monitoring techniques, if made affordable to the patient, would certainly help a large portion of the diabetic population.
Advertisement
In its upcoming web conference taking place on Thursday, 22nd April 2010, at 4 p.m. GMT Frost & Sullivan will therefore focus on the European Continuous Glucose Monitoring Market. Senior Research Analyst, Ms. Akanksha Joshi, will present an analysis of latest trends and developments in the market, competitive factors as well as challenges and strategic recommendations.
To participate in this complimentary briefing, please email Katja Feick at [email protected] with your full contact details. Upon receipt of the above information, a registration link will be e-mailed to you. You may also register to receive a recorded version of the briefing at any time by submitting the aforementioned contact details.
This web conference will benefit manufacturers, distributors, retail shop owners active in the market by discussing emerging trends and providing forward projections for the Continuous Glucose Monitoring market in Europe.
"An increasing awareness regarding diabetes care through continuous glucose monitoring would fuel the European market, and the growth could be stupendous, if the treatment was available at an affordable price," concludes Ms. Joshi.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
Contact: Katja Feick Corporate Communications - Europe P: 0049 (0) 69 77 0 33 43 F: 0049 (0) 69 23 45 66 E: [email protected]
SOURCE Frost & Sullivan
